Sildenafil in Infants and Children - Wikidata - wikimedia - TriplyDB

Sildenafil in Infants and Children

Sildenafil in Infants and Children

http://www.wikidata.org/entity/Q38652768

about

Sildenafil in Infants and Children

http://www.wikidata.org/entity/Q38652768

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Sildenafil in Infants and Children

@en

type

label

Sildenafil in Infants and Children

@en

prefLabel

Sildenafil in Infants and Children

@en

P1433

Q38652768-730199F7-15A0-4C6C-AECE-259B04B41694

P1476

Q38652768-8362AFFE-63FE-4A9E-8000-092BDE2F9FDA

P2093

Q38652768-E87B203A-15B8-4EB4-B109-DE9AE81C4209

P2860

Q38652768-023D3687-2243-4B52-AD3F-8E140776BF6C

Q38652768-0410D3B6-D49D-40D6-BB8C-9CC0C790F816

Q38652768-064AB092-6B84-4729-9B03-E19BEF3CC7FE

Q38652768-10E90A78-DC5B-472A-A8AD-F38E6FD69A3E

Q38652768-1A165AE4-B1BE-4911-9BDB-ED474EE5A552

Q38652768-233D125C-6D75-4502-8F11-2264E5E632D5

Q38652768-2726A390-D41F-4CBC-8A9A-F88251F6F8C7

Q38652768-2D9E777D-561B-4B2A-9900-9288726D4D26

Q38652768-47866873-C416-40D2-B821-69EC981A3F94

Q38652768-4FA1FC01-EBF0-4340-8A43-F038EF941C87

P31

Q38652768-32DE6F53-DE91-4B24-9EC1-0CF5B0DCD404

P356

Q38652768-DB1FDC21-0A5E-4C57-98C4-D91563FE1F0A

P433

Q38652768-5BDB33F4-F688-4F38-B116-3CBED5C6662C

P478

Q38652768-E9E5A872-EF21-4B79-A09A-F7B834BC4294

P50

Q38652768-24314EB0-E55C-4762-9F06-340D7337AAC8

P577

Q38652768-10DDE706-F458-4B55-B340-085B2DB5450E

P698

Q38652768-A96CBEAA-DF62-4FE1-ACAD-C9BDA6247C7D

P932

Q38652768-1ED247BF-491C-4E41-A96F-75D751C5695B

P356

CHILDREN4070060

P1433

Children (Basel, Switzerland)

P1476

Sildenafil in Infants and Children

@en

P2093

Larisa Simonca

http://www.w3.org/2001/XMLSchema#string

P2860

Sildenafil for pulmonary hypertension in neonates

Cellular and molecular basis of RV hypertrophy in congenital heart disease

Phosphodiesterase type 5 is highly expressed in the hypertrophied human right ventricle, and acute inhibition of phosphodiesterase type 5 improves contractility

Pulmonary arterial hypertension in pediatric patients with hematopoietic stem cell transplant-associated thrombotic microangiopathy.

An open-label study to evaluate sildenafil for the treatment of lymphatic malformations

Cyclic GMP phosphodiesterase-5: target of sildenafil.

Pulmonary hypertension in preterm infants with bronchopulmonary dysplasia.

Guanylyl cyclases and signaling by cyclic GMP.

Are phosphodiesterase type 5 inhibitors associated with vision-threatening adverse events? A critical analysis and review of the literature.

Pharmacokinetics of sildenafil after single oral doses in healthy male subjects: absolute bioavailability, food effects and dose proportionality.

P31

scholarly article

P356

10.3390/CHILDREN4070060

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P50

Robert M. Tulloh

P577

2017-07-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28737730

http://www.w3.org/2001/XMLSchema#string

P932

5532552

http://www.w3.org/2001/XMLSchema#string